Literature DB >> 3987683

In vitro activity of five quinoline derivatives against nosocomial isolates of Staphylococcus and Pseudomonas species.

F D Daschner, H M Just.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3987683     DOI： 10.1007/bf02148670

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  4 in total

1.  A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.

Authors:  L Shrire; J Saunders; R Traynor; H J Koornhof
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

2.  Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.

Authors:  J A Hoogkamp-Korstanje
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

3.  In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.

Authors:  A Bauernfeind; C Petermüller
Journal:  Eur J Clin Microbiol       Date:  1983-04       Impact factor: 3.267

4.  In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

Authors:  R Wise; J M Andrews; L J Edwards
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191
  4 in total
  2 in total

Review 1.  [Enoxacin: spectrum and activity of its antibacterial effect].

Authors:  A Bauernfeind; H Flamm; H Grimm; H Hahn; F Kayser; W Opferkuch; J Potel; R Malottke; H G Sonntag; W H Traub
Journal:  Infection       Date:  1986       Impact factor: 3.553

2.  Treatment of respiratory tract infections with pefloxacin in critically ill patients hospitalized in a surgical intensive care unit.

Authors:  D M Boland; W C van Gestel; D M MacLaren; D de Jong
Journal:  Pharm Weekbl Sci       Date:  1987-12-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.